AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3888133 — intervention group
Group type: COMPARATOR
Intervention: Feedback group
Number of subjects: 56
Study 3888133 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 29064340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar tDCS (20 min, 2 mA) with right cathodal stimulation during verb generation task
Number of subjects: 12
Study 29064340 — intervention group
Group type: COMPARATOR
Intervention: Cerebellar tDCS (20 min, 2 mA) with sham stimulation during verb generation task
Number of subjects: 12
Study 29064340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar tDCS (20 min, 2 mA) with right cathodal stimulation during verb naming task
Number of subjects: 12
Study 29064340 — intervention group
Group type: COMPARATOR
Intervention: Cerebellar tDCS (20 min, 2 mA) with sham stimulation during verb naming task
Number of subjects: 12
Study 27424011 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen 650 mg
Number of subjects: 101
Study 27424011 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquefied ibuprofen 400 mg
Number of subjects: 101
Study 27424011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 27424011 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between Acetaminophen and Liquefied Ibuprofen
Number of subjects: 101
Study 24408162 — intervention group
Group type: COMPARATOR
Intervention: Ponesimod 5, 10, or 20 mg
Number of subjects: 10
Study 24408162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ponesimod 40 mg (up-titration schedule)
Number of subjects: 10
Study 24408162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ponesimod (multiple doses)
Number of subjects: 10
Study 22947225 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (500 mg DHA + 150 mg EPA, 400 μg 5-methyltetrahydrofolate)
Number of subjects: 0
Study 22947225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20827544 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (cannulated screw fixation with postoperative splint immobilization for a maximum of 1 week)
Number of subjects: 94
Study 20827544 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (short arm cast until fracture union achieved)
Number of subjects: 94
Study 17960642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy
Number of subjects: 141
Study 15685078 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body positive pressure exercise at 60% body weight
Number of subjects: 15
Study 15685078 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body positive pressure exercise at 20% body weight
Number of subjects: 15
Study 15685078 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body positive pressure ambulation after anterior cruciate ligament reconstruction
Number of subjects: 15
Study 14586246 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alone
Number of subjects: 1251
Study 14586246 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon + ribavirine
Number of subjects: 1251
Study 14586246 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy after unsuccessful monotherapy
Number of subjects: 1251
Study 10230589 — intervention group
Group type: EXPERIMENTAL
Intervention: Heidelberg Retina Flowmeter (HRF) measurements at the papilla with a frame size of 50 x 50 pixels
Number of subjects: 150
Study 8723847 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask insertion with laryngoscope
Number of subjects: 48
Study 8723847 — intervention group
Group type: COMPARATOR
Intervention: Blind laryngeal mask insertion
Number of subjects: 48
Study 2068939 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory brainstem responses (ABRs) test for endolymphatic hydrops
Number of subjects: 30
Study 2068939 — intervention group
Group type: COMPARATOR
Intervention: Glycerol dehydration
Number of subjects: 30
Study 2068939 — intervention group
Group type: COMPARATOR
Intervention: Placebo and two different drugs
Number of subjects: 30
Study 6820890 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole + Mitomycin C + Tegafur
Number of subjects: 155
Study 6820890 — intervention group
Group type: COMPARATOR
Intervention: Control (Mitomycin C + Tegafur)
Number of subjects: 155
Study 31322037 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater perceived friend social support
Number of subjects: 489
Study 31322037 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater perceived familial social support
Number of subjects: 489
Study 31322037 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater social support from both friends and family
Number of subjects: 489
Study 31322037 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater AA/NA participation
Number of subjects: 489
Study 31322037 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 489
Study 29171821 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mg erenumab
Number of subjects: 955
Study 29171821 — intervention group
Group type: EXPERIMENTAL
Intervention: 140 mg erenumab
Number of subjects: 955
Study 29171821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 955
Study 27134522 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol-380
Number of subjects: 225
Study 27134522 — intervention group
Group type: COMPARATOR
Intervention: Iohexol-350
Number of subjects: 225
Study 27134522 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 225
Study 25491514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental health education by qualified dentists and school teachers with supply of oral hygiene aids
Number of subjects: 15
Study 25491514 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental health education by qualified dentists and school teachers without supply of oral hygiene aids
Number of subjects: 15
Study 25491514 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 15
Study 22316412 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐specific education with a mailed reminder
Number of subjects: 256
Study 22316412 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 256
Study 19224307 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-incision approach
Number of subjects: 24
Study 19224307 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-posterior approach
Number of subjects: 24
Study 19224307 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-anterolateral approach
Number of subjects: 24
Study 19224307 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive postoperative rehabilitation program
Number of subjects: 24
Study 17469045 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg) for two weeks
Number of subjects: 9
Study 17469045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 15094147 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal voluntary isometric contractions (MVC)
Number of subjects: 11
Study 15094147 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-maximal voluntary isometric contractions (sub-MVC)
Number of subjects: 11
Study 15094147 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-MVC
Number of subjects: 11
Study 15094147 — intervention group
Group type: EXPERIMENTAL
Intervention: MVC
Number of subjects: 11
Study 12575338 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 60
Study 12575338 — intervention group
Group type: EXPERIMENTAL
Intervention: Amilodipine
Number of subjects: 60
Study 9794673 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of mifepristone
Number of subjects: 80
Study 9794673 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg of mifepristone
Number of subjects: 80
Study 9794673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 7641744 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser ablation
Number of subjects: 642
Study 7641744 — intervention group
Group type: COMPARATOR
Intervention: LETZ
Number of subjects: 642
Study 7641744 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV positive
Number of subjects: 642
Study 7641744 — intervention group
Group type: COMPARATOR
Intervention: No HPV infection
Number of subjects: 642
Study 2750681 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation from birth
Number of subjects: 2
Study 2750681 — intervention group
Group type: COMPARATOR
Intervention: Unsupplemented
Number of subjects: 2
Study 208473 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered attenuated poliovaccine
Number of subjects: 230
Study 208473 — intervention group
Group type: EXPERIMENTAL
Intervention: Formalin‐killed poliomyelitis vaccine (inactivated poliovaccine)
Number of subjects: 230
Study 208473 — intervention group
Group type: COMPARATOR
Intervention: No vaccine (control group)
Number of subjects: 230
Study 31707829 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/d
Number of subjects: 3146
Study 31707829 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3146
Study 30925147 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP at 10 cm H₂O (P10)
Number of subjects: 60
Study 30925147 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP at 15 cm H₂O (P15)
Number of subjects: 60
Study 30925147 — intervention group
Group type: COMPARATOR
Intervention: PEEP at 0 cm H₂O (P0)
Number of subjects: 60
Study 29390476 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous nephrolithotomy (UGPN)
Number of subjects: 86
Study 29390476 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic-guided percutaneous nephrolithotomy (FGPN)
Number of subjects: 86
Study 26114843 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone ophthalmoscopy (SO) by ophthalmology resident (OR)
Number of subjects: 94
Study 26114843 — intervention group
Group type: COMPARATOR
Intervention: Fundus camera (FC) images
Number of subjects: 94
Study 23904575 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC restoration with RMGI liner
Number of subjects: 341
Study 23904575 — intervention group
Group type: COMPARATOR
Intervention: RBC restoration without RMGI liner
Number of subjects: 341
Study 22313929 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z250 placed incrementally (ZI)
Number of subjects: 12
Study 22313929 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z250 placed in bulk (ZB)
Number of subjects: 12
Study 22313929 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Silorane placed incrementally (SI)
Number of subjects: 12
Study 22313929 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Silorane placed in bulk (SB)
Number of subjects: 12
Study 18077214 — intervention group
Group type: EXPERIMENTAL
Intervention: HamSprint programme
Number of subjects: 29
Study 18077214 — intervention group
Group type: COMPARATOR
Intervention: Usual warm-up (stretching, running, and increasingly intense football drills)
Number of subjects: 29
Study 18318195 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinpotropil
Number of subjects: 0
Study 18318195 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortexin
Number of subjects: 0
Study 18318195 — intervention group
Group type: EXPERIMENTAL
Intervention: Noopept
Number of subjects: 0
Study 18318195 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilept
Number of subjects: 0
Study 15645323 — intervention group
Group type: EXPERIMENTAL
Intervention: Open appendectomy
Number of subjects: 37
Study 15645323 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic appendectomy
Number of subjects: 37
Study 12433510 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous melagatran followed by oral ximelagatran (dose categories: 1.00 mg, 1.50 mg, 2.25 mg, or 3.00 mg twice daily; followed by 8 mg, 12 mg, 18 mg, or 24 mg twice daily)
Number of subjects: 1900
Study 12433510 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous dalteparin 5000 IU once daily
Number of subjects: 1900
Study 9818340 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetazolamide, 500 mg 1 hour preoperatively
Number of subjects: 202
Study 9818340 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetazolamide, 500 mg immediately postoperatively
Number of subjects: 202
Study 9818340 — intervention group
Group type: EXPERIMENTAL
Intervention: Apraclonidine hydrochloride 1%, 2 drops 1 hour preoperatively
Number of subjects: 202
Study 9818340 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (control group)
Number of subjects: 202
Study 7851351 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (induction 1.5 micrograms kg‐1 plus infusion 1.5 micrograms kg‐1 h‐1)
Number of subjects: 22
Study 7851351 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (induction 10 micrograms kg‐1 plus infusion 10 micrograms kg‐1 h‐1)
Number of subjects: 22
Study 2553180 — intervention group
Group type: EXPERIMENTAL
Intervention: Late intensification with autologous bone marrow transplantation
Number of subjects: 101
Study 2553180 — intervention group
Group type: COMPARATOR
Intervention: Conventional post-induction therapy
Number of subjects: 101
Study 4164930 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (doses above 150 mg per day)
Number of subjects: 30
Study 4164930 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 30
Study 28950430 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study 28950430 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA)
Number of subjects: 0
Study 28950430 — intervention group
Group type: EXPERIMENTAL
Intervention: ADA + MTX combination therapy
Number of subjects: 0
Study 28950430 — intervention group
Group type: EXPERIMENTAL
Intervention: Low hemoglobin concentrations over time
Number of subjects: 0
Study 28950430 — intervention group
Group type: EXPERIMENTAL
Intervention: Low hemoglobin concentrations
Number of subjects: 0
Study 28950430 — intervention group
Group type: EXPERIMENTAL
Intervention: Low disease activity (DAS28-CRP < 3.2)
Number of subjects: 0
Study 28298244 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual administration of anesthetics guided by BIS sensor
Number of subjects: 430
Study 28298244 — intervention group
Group type: COMPARATOR
Intervention: Automated administration of anesthetics
Number of subjects: 430
Study 25786858 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention (TI)
Number of subjects: 356
Study 25786858 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed intervention (MI)
Number of subjects: 356
Study 25786858 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 356
Study 23788583 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO
Number of subjects: 90
Study 23788583 — intervention group
Group type: EXPERIMENTAL
Intervention: rtPA+placebo
Number of subjects: 90
Study 23788583 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 90
Study 23788583 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO+rtPA
Number of subjects: 90
Study 20604699 — intervention group
Group type: EXPERIMENTAL
Intervention: Negotiated follow-up with telephone reinforcement (TR)
Number of subjects: 0
Study 20604699 — intervention group
Group type: COMPARATOR
Intervention: Negotiated-only
Number of subjects: 0
Study 20604699 — intervention group
Group type: COMPARATOR
Intervention: Mainstreamed-with-TR
Number of subjects: 0
Study 20604699 — intervention group
Group type: COMPARATOR
Intervention: Mainstreamed-only
Number of subjects: 0
Study 20604699 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone reinforcement (TR)
Number of subjects: 0
Study 18202988 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion of research, faculty modeling, and role-playing
Number of subjects: 0
Study 18202988 — intervention group
Group type: COMPARATOR
Intervention: Discussion of research and role-playing
Number of subjects: 0
Study 15867173 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-chamber pacing
Number of subjects: 2010
Study 15867173 — intervention group
Group type: COMPARATOR
Intervention: Ventricular pacing
Number of subjects: 2010
Study 12869078 — intervention group
Group type: EXPERIMENTAL
Intervention: Tioguanine (40 mg tablet preparation)
Number of subjects: 6
Study 10384971 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliance urinary control insert
Number of subjects: 63
Study 8678493 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapies
Number of subjects: 84
Study 1987962 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual expression with clean containers
Number of subjects: 16
Study 1987962 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual expression with sterile containers
Number of subjects: 16
Study 1987962 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical expression with clean containers
Number of subjects: 16
Study 1987962 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical expression with sterile containers
Number of subjects: 16
Study 1987962 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial milk expressed
Number of subjects: 16
Study 1987962 — intervention group
Group type: COMPARATOR
Intervention: Clean containers
Number of subjects: 16
Study 1987962 — intervention group
Group type: COMPARATOR
Intervention: Sterile containers
Number of subjects: 16
Study 1987962 — intervention group
Group type: COMPARATOR
Intervention: Manual technique
Number of subjects: 16
Study 1987962 — intervention group
Group type: COMPARATOR
Intervention: Mechanical technique
Number of subjects: 16
Study 7033581 — intervention group
Group type: EXPERIMENTAL
Intervention: lodoxamide ethyl
Number of subjects: 13
Study 7033581 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study 30444772 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic apicoectomy with endoscopic sinus surgery (ESS)
Number of subjects: 21
Study 30444772 — intervention group
Group type: COMPARATOR
Intervention: Control group (tooth extraction)
Number of subjects: 21
Study 29402141 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirasemtiv (125 mg twice a day, escalating to 250, 375, or 500 mg)
Number of subjects: 0
Study 29402141 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirasemtiv (various doses)
Number of subjects: 0
Study 29402141 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26894313 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief phone-based cognitive-behavioral intervention
Number of subjects: 0
Study 26894313 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no specific intervention mentioned)
Number of subjects: 0
Study 24535455 — intervention group
Group type: EXPERIMENTAL
Intervention: Rikkunshito (RKT) + rabeprazole (10 mg/day) for 8 weeks
Number of subjects: 242
Study 24535455 — intervention group
Group type: COMPARATOR
Intervention: Placebo + rabeprazole (10 mg/day) for 8 weeks
Number of subjects: 242
Study 22310081 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 mm incision size
Number of subjects: 120
Study 22310081 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.2 mm incision size
Number of subjects: 120
Study 22310081 — intervention group
Group type: COMPARATOR
Intervention: 3.0 mm incision size
Number of subjects: 120
Study 19308708 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory workplace intervention
Number of subjects: 40
Study 17388233 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 2 mg/kg (E2)
Number of subjects: 165
Study 17388233 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol 1 mg/kg (E1)
Number of subjects: 165
Study 17388233 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Eplac)
Number of subjects: 165
Study 16216469 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CRO) 100mg/kg once daily
Number of subjects: 33
Study 16216469 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (CTX) 50 mg/kg 6 hourly
Number of subjects: 33
Study 11880563 — intervention group
Group type: EXPERIMENTAL
Intervention: lactolycopene
Number of subjects: 33
Study 11880563 — intervention group
Group type: EXPERIMENTAL
Intervention: tomato paste
Number of subjects: 33
Study 11880563 — intervention group
Group type: COMPARATOR
Intervention: placebo (whey proteins)
Number of subjects: 33
Study 10199349 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective caesarean-section delivery
Number of subjects: 436
Study 10199349 — intervention group
Group type: COMPARATOR
Intervention: Vaginal delivery
Number of subjects: 436
Study 10199349 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual caesarean-section delivery
Number of subjects: 436
Study 10199349 — intervention group
Group type: COMPARATOR
Intervention: Actual vaginal delivery
Number of subjects: 436
Study 7776183 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased exposure to target individual
Number of subjects: 0
Study 7776183 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback about the target's actual thoughts and feelings
Number of subjects: 0
Study 7776183 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-target consistency in responding
Number of subjects: 0
Study 2108852 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin with thrombolytic therapy
Number of subjects: 0
Study 2108852 — intervention group
Group type: COMPARATOR
Intervention: Thrombolytic therapy alone
Number of subjects: 0
Study 7353381 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxycholecalciferol (1,25[OH]2D3)
Number of subjects: 0
Study 7353381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30606246 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular oxytocin
Number of subjects: 5712
Study 30606246 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular oxytocin/ergometrine
Number of subjects: 5712
Study 30606246 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular carbetocin
Number of subjects: 5712
Study 29485925 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids (lactated Ringer's solution or Plasma‐Lyte A)
Number of subjects: 15802
Study 29485925 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.9% sodium chloride)
Number of subjects: 15802
Study 29485925 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced crystalloids
Number of subjects: 15802
Study 29485925 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15802
Study 26763727 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 180 mg loading dose (LD)
Number of subjects: 74